Looking to publish in Cancer Gene Therapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginCancer Gene Therapy is a journal focused on gene and cellular therapy for cancer researchers and clinicians.
Looking to publish in Cancer Gene Therapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
Cancer Gene Therapy accepts the following article types. Click on an article type to view submission instructions.
Article
Review Article
Brief Communication
Correspondence
Perspective
Recent Publications
HOXC11 promotes head and neck squamous cell carcinomas (HNSCC) progression by regulating SPHK1 through the Wnt signaling pathway
Jing Zhang, Qionghui Wu, Jingyuan Liu, Shisheng Li
Glypican-3-targeted therapy in hepatocellular carcinoma: biological insights and therapeutic strategies
Na Li, Shurong Li, Peng Cao, Mengfan Tang, Junfeng Zhang, Wei Zhang, Jinfeng Liu, Chunping Ye, Dan Wu, Xixi Li, Li Dai, Xianglin Zuo
Target therapeutic exploitation of engineered exosome-mediated delivery of ncRNAs in cancer
Fatemeh Chaharlang, Nafiseh Mahdipour, Sana Alizadeh Rami, Parichehr Angouti, Alireza Ahmadi, Mohammad Khalaj-Kondori
Targeting RAB27A-mediated small extracellular vesicle secretion via CRISPR-Cas9 negatively affects proliferation and metastasis in both in vitro and in vivo SCLC models
Onur Tokgün, Kubilay İnci, Aziz Gültekin, Büşra Çelikkaya, Nesrin İrep, Hakan Akça, Pervin Elvan Tokgün
CagA promotes gastric cancer stemness and metastasis via DNMT1-mediated epigenetic silencing of BEX1
Yan Wang, Dajun Chen, Shuai Qian, Fengping Wang, Huibin Weng
Frequently asked questions
How long does it take to publish?
Submission to first editorial decision: 5 median days. Submission to acceptance: 138 median days.
Reformat to Cancer Gene Therapy using Livewrite PremiumIs a cover letter required?
A cover letter on institutional letterhead is required at first submission.
Reformat to Cancer Gene Therapy using Livewrite PremiumWhat are the publication costs?
Standard publication is behind a paywall. Gold open access is available with an APC of £2,990 / $4,290 / €3,490, plus VAT or local taxes where applicable.
Reformat to Cancer Gene Therapy using Livewrite Premium